Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching

AIM: To compare efficacy of telaprevir (TVR) and simeprevir (SMV) combined with pegylated interferon (PEG-IFN) and ribavirin (RBV) while treating chronic hepatitis C (CHC). METHODS: In all, 306 CHC patients were included in this study. There were 159 patients in the TVR combination therapy group and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Hepatol
Asıl Yazarlar: Fujii, Hideki, Nishimura, Takeshi, Umemura, Atsushi, Nishikawa, Taichiro, Yamaguchi, Kanji, Moriguchi, Michihisa, Sumida, Yoshio, Mitsuyoshi, Hironori, Yokomizo, Chihiro, Tanaka, Saiyu, Ishikawa, Hiroki, Nishioji, Kenichi, Kimura, Hiroyuki, Takami, Shiro, Nagao, Yasuyuki, Takeuchi, Takayuki, Shima, Toshihide, Sawa, Yoshihiko, Minami, Masahito, Yasui, Kohichiroh, Itoh, Yoshito
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2015
Konular:
Retrospective Cohort Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4670956/
https://ncbi.nlm.nih.gov/pubmed/26668696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i28.2841
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller